LLY
1,021.52
+0.37%↑
JNJ
195.34
+0.5%↑
ABBV
232.46
-0.34%↓
UNH
332.18
-2.03%↓
AZN
88.54
+0.99%↑
LLY
1,021.52
+0.37%↑
JNJ
195.34
+0.5%↑
ABBV
232.46
-0.34%↓
UNH
332.18
-2.03%↓
AZN
88.54
+0.99%↑
LLY
1,021.52
+0.37%↑
JNJ
195.34
+0.5%↑
ABBV
232.46
-0.34%↓
UNH
332.18
-2.03%↓
AZN
88.54
+0.99%↑
LLY
1,021.52
+0.37%↑
JNJ
195.34
+0.5%↑
ABBV
232.46
-0.34%↓
UNH
332.18
-2.03%↓
AZN
88.54
+0.99%↑
LLY
1,021.52
+0.37%↑
JNJ
195.34
+0.5%↑
ABBV
232.46
-0.34%↓
UNH
332.18
-2.03%↓
AZN
88.54
+0.99%↑
24h
Current
Min
2.4
Max
2.61
Recommendations | Buy |
|---|---|
12 Months Forecast | +453.44% upside |
Next Earnings | 19 lis 2025 |
|---|
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
1 paź 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Read
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Read
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Read
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Read
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Read
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Read
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 14.5 USD 453.44%
High 17 USD
Low 12 USD
Based on 2 Wall Street analysts offering 12 month price targets forFortress Biotech Inc - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Based on 2 analysts giving stock ratings to Fortress Biotech Inc - Dist in the past 3 months.
$